Home › Merck expects no writedowns for Zetia, Vytorin cholesterol drugs
 

Keywords :   


Merck expects no writedowns for Zetia, Vytorin cholesterol drugs

2014-11-11 04:01:13| Biotech - Topix.net

Merck & Co on Monday said long-awaited data from an 18,000-patient trial suggest the company will not have to write down the value of its blockbuster Zetia and Vytorin cholesterol drugs. "The company has determined that the Zetia and Vytorin intangible assets are not impaired," the No.

Tags: drugs expects cholesterol merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Easing US inflation stokes interest rate cut debate
15.05Free From Skincare Award Finalists Announced
15.05Sub-postmasters are self-indulgent, said PO exec
15.05Axalta Hosting Strategy Day; Outlining Three-Year Plan for Accelerating Performance
15.05Pork has its place in healthy, sustainable global diets
15.05BASF Paves the Way for Young Painters at WorldSkills Finals Lyon 2024
15.05Orchard Custom Beauty to Showcase New Product Concepts at PLMA World of Private Label in Amsterdam
15.05Sontara Offers Sri Flo Wipes
More »